Emerging Drug Developer: LEAD Therapeutics
Emerging Drug Developer: LEAD Therapeutics
For up-start LEAD Therapeutics, the business plan is written right into the name. But behind the catchy acronym in play you'll find a group of experienced chemists and biotech executives with some interesting ideas about structuring a new kind of drug discovery company that can build on a low-cost equation in China while exploiting new trends in the pharma business. Their experience offers some insights into capturing the attention of venture capitalists. Article
Want more on emerging drug developers? Check out our archives.
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness


